GXGX GX Acquisition Corp.

Subscribe to $GXGX

GX Acquisition Corp.

Subscribe to $GXGX

$GXGX

Business Services

Finance

IPO Year: 2019

Exchange: NASDAQ

Recent Analyst Ratings for GX Acquisition Corp.

Date	Price Target	Rating	Analyst

See more ratings

GX Acquisition Corp. Press Releases

Fastest customizable press release news feed in the world

View All

GX Acquisition Corp. Announces Shareholder Approval of Extension Proposal

NEW YORK, May 14, 2021 /PRNewswire/ -- GX Acquisition Corp. ("GX") (NASDAQ:GXGX), a publicly-traded special purpose acquisition company, announced today that its stockholders have voted to approve an amendment to GX's amended and restated certificate of incorporation to extend the date by which GX must effectuate its initial business combination from May 23, 2021 to July 31, 2021. As previously disclosed, on January 8, 2021, GX entered into a Merger Agreement and Plan of Reorganization (the "Merger Agreement") with Celularity Inc. ("Celularity"), Alpha First Merger Sub, Inc. and Alpha Second Merger Sub, LLC. Upon the terms and subject to the conditions of the Merger Agreement, Celularity wi

5/14/21 4:45:00 PM ET

$GXGX

Business Services

Finance

GX Acquisition Corp. Announces Additional Contributions to Trust Account

NEW YORK, May 10, 2021 /PRNewswire/ -- GX Acquisition Corp. ("GX") (NASDAQ:GXGX), a publicly-traded special purpose acquisition company, today reaffirmed its intention to support the proposal to amend GX's amended and restated certificate of incorporation to extend the date by which GX must complete its initial business combination from May 23, 2021 to July 31, 2021 (the "Extension" and such later date, the "Extended Date"). This proposal will be voted on by stockholders at the upcoming special meeting of stockholders on May 14, 2021. The Extension will allow GX until the Extended Date to complete its initial business combination. In order to support this proposal, GX has agreed that, if the

5/10/21 7:30:00 AM ET

$GXGX

Business Services

Finance

Celularity Enters into Multi-Year Strategic Partnership with Palantir Technologies

Celularity to leverage Palantir's next generation software and computational capabilities with their deep cellular data set to accelerate research and development activities Partnership includes equity investment by Palantir in Celularity Investment, combined with previously announced PIPE investment, brings over$100 million in new funding to Celularity FLORHAM PARK, N.J., May 05, 2021 (GLOBE NEWSWIRE) -- Celularity Inc. ("Celularity"), a clinical-stage biotechnology company leading the next evolution in cellular medicine with the development of off-the-shelf allogeneic therapies derived from the postpartum human placenta, and Palantir Technologies Inc. (NYSE:PLTR), a software company t

5/5/21 8:00:00 AM ET

$PLTR

$GXGX

Computer Software: Prepackaged Software

Technology

Business Services

Finance

GX Acquisition Corp. Provides Information Regarding Extension of Deadline to Complete Celularity Business Combination

NEW YORK, April 16, 2021 /PRNewswire/ -- On April 14, 2021, GX Acquisition Corp. ("GX") (NASDAQ: "GXGX"), provided information regarding a proposal to amend GX's amended and restated certificate of incorporation (the "Charter") to extend the date by which GX has to complete its initial business combination (the "Extension") from May 23, 2021 to July 31, 2021. The Charter currently provides that GX has 24 months from the closing of its initial public offering (until May 23, 2021) to complete an initial business combination, which is customary for a special purpose acquisition company like GX. As previously announced, in January 2021 GX entered into a definitive merger agreement with Celularit

4/16/21 7:00:00 AM ET

$GXGX

Business Services

Finance

Celularity and GX Acquisition Corp. Announce Merger Agreement to Create a Publicly Listed Leader in Allogeneic Cellular Therapy

FLORHAM PARK, N.J. and NEW YORK, Jan. 8, 2021 /PRNewswire/ -- Celularity Inc. ("Celularity"), a clinical-stage biotechnology company, leading the next evolution in cellular medicine with the development of off-the-shelf allogeneic therapies derived from the postpartum human placenta, and GX Acquisition Corp. (Nasdaq: GXGX), a special purpose acquisition company, today announced they have entered into a definitive merger agreement pursuant to which GX Acquisition Corp. will combine with Celularity. Upon the closing of the transaction, which is expected to occur in the second quarter of 2021, GX Acquisition Corp. will be renamed Celularity Inc., and its common stock and warrants are expecte

1/8/21 7:00:00 AM ET

$GXGX

Business Services

Finance

GX Acquisition Corp.

Recent Analyst Ratings for GX Acquisition Corp.

GX Acquisition Corp.

Recent Analyst Ratings for GX Acquisition Corp.

GX Acquisition Corp. Analyst Ratings

BTIG Research initiated coverage on GX Acquisition Corp with a new price target

GX Acquisition Corp. Press Releases

GX Acquisition Corp. Announces Shareholder Approval of Extension Proposal

GX Acquisition Corp. Announces Additional Contributions to Trust Account

Celularity Enters into Multi-Year Strategic Partnership with Palantir Technologies

GX Acquisition Corp. Provides Information Regarding Extension of Deadline to Complete Celularity Business Combination

Celularity and GX Acquisition Corp. Announce Merger Agreement to Create a Publicly Listed Leader in Allogeneic Cellular Therapy

GX Acquisition Corp. Insider Trading

SEC Form 4 filed by Pecora Andrew L

SEC Form 3 filed by new insider Pecora Andrew L

SEC Form 4 filed by Mirakhur Beloo

SEC Form 3 filed by new insider Mirakhur Beloo

SEC Form 4 filed by Brigido Stephen

SEC Form 4 filed by Smith Robin L

SEC Form 4 filed by Hariri Robert J

SEC Form 4 filed by Diamandis Peter

SEC Form 4 filed by Mazur Marc

SEC Form 4 filed by Lim Kok Thay

GX Acquisition Corp. SEC Filings

SEC Form S-8 filed by GX Acquisition Corp.

SEC Form 424B3 filed by GX Acquisition Corp.

SEC Form 8-K filed by GX Acquisition Corp.

SEC Form 424B3 filed by GX Acquisition Corp.

SEC Form 424B3 filed by GX Acquisition Corp.

SEC Form 424B3 filed by GX Acquisition Corp.

SEC Form 10-Q filed by GX Acquisition Corp.

SEC Form NT 10-Q filed by GX Acquisition Corp.

SEC Form 8-K/A filed by GX Acquisition Corp. (Amendment)

SEC Form 8-K filed by GX Acquisition Corp.

GX Acquisition Corp. Large Ownership Changes

SEC Form SC 13G filed by GX Acquisition Corp.

SEC Form SC 13D filed by GX Acquisition Corp.

SEC Form SC 13G filed by GX Acquisition Corp.

SEC Form SC 13D filed by GX Acquisition Corp.

SEC Form SC 13G filed by GX Acquisition Corp.

SEC Form SC 13G filed by GX Acquisition Corp.

SEC Form SC 13G/A filed by GX Acquisition Corp. (Amendment)

SEC Form SC 13G filed by GX Acquisition Corp.

SEC Form SC 13G filed by GX Acquisition Corp.

SEC Form SC 13G filed by GX Acquisition Corp.